Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Favrole, P.
Right arrow Articles by Woimant, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Favrole, P.
Right arrow Articles by Woimant, F.
Related Collections
Right arrow DWI
Right arrow All Medical/Systemic disease
Right arrow Metabolic disease (inherited)
Right arrow All Movement Disorders
NEUROLOGY 2006;66:384-389
© 2006 American Academy of Neurology

Clinical correlates of cerebral water diffusion in Wilson disease

P. Favrole, MD, H. Chabriat, MD, PhD, J. P. Guichard, MD and F. Woimant, MD

From the Departments of Neurology (P.F., H.C., F.W.) and Neuroradiology (J.P.G.), Lariboisiere Hospital, Paris, France.

Address correspondence and reprint requests to Dr. P. Favrole, Department of Neurology, Lariboisiere Hospital, 2 rue Ambroise Paré, 75475 Paris, France; e-mail: pascal.favrole{at}lrb.ap-hop-paris.fr

Objective: To investigate the course of diffusion changes in Wilson disease (WD) and to evaluate their clinical and radiologic correlates.

Methods: MRI with fluid-attenuated inversion recovery (FLAIR) and diffusion weighted images (DWI) were performed in 13 symptomatic patients with WD who had typical neurologic manifestations of the disease (sWD patients) and in 5 presymptomatic patients (psWD patients). Follow-up clinical and MRI data were obtained in 12/13 patients with sWD. Ten subjects without neurologic disease and with normal cerebral MRI were used as controls. Apparent diffusion coefficient (ADC) was measured in areas where hyperintense lesions were detected on FLAIR images and in the normal-appearing white matter.

Results: Hyperintense lesions were detected in all symptomatic patients on FLAIR MR images but only in 11 of 13 patients with sWD on DWI. These lesions were absent in patients with psWD. The mean ADC was found increased in the putamen, pallidum, internal capsule, mesencephalon, and within the white matter in the symptomatic group in comparison to controls. This was not observed in patients with psWD, who even had a decreased ADC in the putamen. A significant correlation was found between the increase in diffusion and the modified Rankin Scale in presence of symptoms. Moreover, the variation of the clinical scale was significantly correlated with the variation of diffusion in the putamen of symptomatic patients.

Conclusion: A decrease in diffusion in the putamen can be detected before the occurrence of neurologic manifestations in WD. In contrast, a large increase in diffusion is detected after the occurrence of symptoms within the putamen, pallidum, internal capsule, and subcortical white matter parallel to the signal changes as seen on fluid-attenuated inversion recovery and diffusion weighted images.

Disclosure: The authors report no conflicts of interest.

Received March 15, 2005. Accepted in final form October 19, 2005.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.